ArticleTranslational breast cancer research : a journal focusing on translational research in breast cancer2022

A new pathological assessment method to assess residual lesions after neoadjuvant chemotherapy for breast cancer, residual disease in breast and nodes combined with Ki-67 (RDBN-K).

Ruoqi Han et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.